PictorLabs, a Los Angeles, CA-based digital pathology firm, raised $15.2M in funding.
The spherical was led by M Ventures, SCC Soft Computer, and Koç Holding.
The firm intends to make use of the funds to develop its biomarker portfolio, develop novel merchandise, develop its expertise base, and construct out its company infrastructure.
Founded by Aydogan Ozcan and Yair Rivenson, PictorLabs is a digital pathology firm offering AI digital staining know-how to innovate histopathology and speed up medical analysis with the purpose of bettering affected person outcomes. The firm’s know-how applies deep studying algorithms to effectively and precisely stain tissues in silico, producing near-instantaneous digital stains. From a single unstained tissue pattern, its proprietary platform can produce a vast variety of digital stains which can be indistinguishable from analogous chemical stains. PictorLabs is growing merchandise that replicate customary of care stains and is creating specialised digital biomarker stains for indications in which there’s a big demand for novel and accelerated diagnostic assessments.
Recently, PictorLabs established a partnership with Charles River Laboratories as a part of their sustainability initiatives to cut back water consumption and chemical waste via the adoption of digital staining know-how.
Since its founding in 2019, the corporate has raised $18.8M.